Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul L Beck

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Gastroenterology|November 7, 2017
Not Your Ordinary Ulcer: A Cautionary Tale of an Uncommon ConditionHenry H Nguyen, Paul L Beck
Canadian Family Physician Medecin De Famille Canadien|December 16, 2004
Clostridium difficile-associated colitisMark W Hull, Paul L Beck
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 27, 2004
There may be a way to say "NO" to gastric injury associated with the combined use of aspirin and cyclooxygenase-2 inhibitorsJennifer J Williams, Paul L Beck
Current Opinion in Gastroenterology|February 11, 2005
Diagnosis of portal hypertensive gastropathyKelly W Burak, Paul L Beck
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 18, 2003
Octreotide treatment of massive hemorrhage due to cytomegalovirus colitisChristopher N Andrews, Paul L Beck
Plos One|April 25, 2013
Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4Indranil Dey, Paul L Beck, Kris Chadee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 14, 2003
Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and managementAyman A Abdo, Stefan J Urbanski, Paul L Beck
Recent Patents on Inflammation & Allergy Drug Discovery|January 20, 2009
Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel diseaseSimon A Hirota, Paul L Beck, Justin A MacDonald
Chest|February 9, 2002
Simple construction of a subcutaneous catheter for treatment of severe subcutaneous emphysemaPaul L Beck, Steven J Heitman, Christopher H Mody
Journal of Innate Immunity|November 10, 2011
Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseasesD Randal Mason, Paul L Beck, Daniel A Muruve
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Gastroenterology|November 7, 2017
Not Your Ordinary Ulcer: A Cautionary Tale of an Uncommon ConditionHenry H Nguyen, Paul L Beck
Canadian Family Physician Medecin De Famille Canadien|December 16, 2004
Clostridium difficile-associated colitisMark W Hull, Paul L Beck
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 27, 2004
There may be a way to say "NO" to gastric injury associated with the combined use of aspirin and cyclooxygenase-2 inhibitorsJennifer J Williams, Paul L Beck
Current Opinion in Gastroenterology|February 11, 2005
Diagnosis of portal hypertensive gastropathyKelly W Burak, Paul L Beck
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 18, 2003
Octreotide treatment of massive hemorrhage due to cytomegalovirus colitisChristopher N Andrews, Paul L Beck
Plos One|April 25, 2013
Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4Indranil Dey, Paul L Beck, Kris Chadee
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 14, 2003
Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and managementAyman A Abdo, Stefan J Urbanski, Paul L Beck
Recent Patents on Inflammation & Allergy Drug Discovery|January 20, 2009
Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel diseaseSimon A Hirota, Paul L Beck, Justin A MacDonald
Chest|February 9, 2002
Simple construction of a subcutaneous catheter for treatment of severe subcutaneous emphysemaPaul L Beck, Steven J Heitman, Christopher H Mody
Journal of Innate Immunity|November 10, 2011
Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseasesD Randal Mason, Paul L Beck, Daniel A Muruve
Pageof 12